/images/ppid_59c68470-image-178474002784027238.webp)
/images/ppid_59c68470-image-178474002427816171.webp)
What is the story about?
Markets retreat as oil rally weighs on sentiment
Indian equity benchmarks ended sharply lower on Wednesday as surging crude oil prices, weakness in heavyweight stocks and renewed concerns over US tariffs on generic drugs dented investor sentiment. The Nifty slipped below the key 24,000 mark, while the rupee weakened against the dollar and foreign institutional investors (FIIs) turned net sellers after a day's pause. In the corporate space, Dr Reddy's Laboratories reported a disappointing set of June-quarter earnings, adding to the cautious mood around pharmaceutical stocks.
Market at close: Dalal Street ends in red as Nifty closes around 23,900FIIs turn sellers again after a day's pause as markets end lower
Foreign institutional investors (FIIs) turned net sellers of Indian equities on Wednesday, offloading shares worth ₹819.20 crore on a provisional basis, according to exchange data.
Read more
Rupee falls to 96.34 against dollar after giving up gains as oil rally intensifies
The Indian rupee opened lower on Wednesday (July 22), reversing some of the gains from the previous session, as a rise in crude oil prices following fresh US-Iran strikes weighed on investor sentiment.
Read more
Also read: Brent crude prices cross $91, hit two-month high; Here are two main reasons why
Dr Reddy's Q1 Results: Semaglutide API provision weighs on profit; margin halves
Dr Reddy's Laboratories reported a weak set of earnings for the June quarter, with profit, revenue and operating performance missing CNBC-TV18 estimates by a wide margin. The pharmaceutical major also posted a sharp year-on-year decline across key financial metrics, underscoring pressure on profitability during the quarter.
Read more
Also Read:Eternal Q1 Results: Blinkit operating profit crosses ₹100 crore, Food delivery NOV up 20%
Can Dalal Street find its footing after Wednesday's rout?
After Wednesday's sharp sell-off, investors will look for signs of stability as elevated crude oil prices continue to dominate market sentiment. Besides the technical setup for the Nifty, traders will track key earnings, stock-specific developments and the pharmaceutical sector's response to US President Donald Trump's proposed tariffs on imported generic medicines.
Stocks to watch for July 23: HPCL, Dr Reddy's Lab, IndusInd Bank and more
From HPCL, Dr Reddy's Lab, IndusInd Bank and others reporting their Q1 results to Auto component maker Sona BLW Precision Forgings Ltd announcing a partnership with DENSO Corporation; these are stocks to track ahead of Thursday trading session.
Read more Nifty Outlook for July 23: Oil prices continue to play bummer as supports break
After having played where to go next for the first couple of days of the week, the Nifty 50 has taken a decisive leg down. Higher oil prices are to blame. Brent is back at $95 and Goldman Sachs is worried that if this disruption lasts longer, they could even go to $120 a barrel in the fourth quarter of the year.
Read more
Indian pharma weighs Trump tariff impact; industry body says US investments hinge on viability
India's pharmaceutical industry is assessing the implications of US President Donald Trump's proposed tariffs on imported generic medicines, but future investments in the US will continue to depend on commercial viability rather than policy announcements alone, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said.
Read more
From geopolitics to technology: Stories in focus
Donald Trump's approval of a Saudi nuclear cooperation deal added a fresh geopolitical dimension to developments in West Asia, while Sonam Wangchuk vowed to continue his hunger strike amid the ongoing NEET row. On the corporate front, Temasek reaffirmed its confidence in India's quick commerce opportunity, while Samsung's latest financial services push and OpenAI's AI testing disclosure kept the technology sector in focus.
Trump approves Saudi nuclear deal: Can Riyadh now build an atomic bomb?
US President Donald Trump has reportedly approved a nuclear cooperation agreement with Saudi Arabia that could eventually allow the kingdom to enrich uranium as part of its civilian nuclear programme.
Read more
Sonam Wangchuk to continue hunger strike until protesters get legal protection
Social activist Sonam Wangchuk has warned he will continue his hunger strike "indefinitely" unless the government guarantees that young protesters who marched on Parliament this week will face no legal action, in a letter to two Union Ministers that also credits them with a fresh assurance on compensation and accountability over an examination paper leak.
Read more
Also read: NEET row rocks Parliament again; govt ready for debate, Kharge demands education minister resign first
Samsung launches Galaxy Card in US: How the tech giant’s first credit card works
Samsung Electronics has entered the US credit card market with the launch of Samsung Galaxy Card, a co-branded credit card issued by Barclays US Consumer Bank and operating on the Visa network.
Read more
Also read: OpenAI's AI models hacked a rival startup without human help, company admits
Temasek unfazed by quick commerce wars, says ‘it’s just the tip of the iceberg’
Singapore state investor Temasek remains firmly bullish on India’s quick commerce opportunity despite intensifying competition from Amazon, Flipkart and Zepto, saying the sector is still in its infancy and has a long runway for growth.
Read more
Indian equity benchmarks ended sharply lower on Wednesday as surging crude oil prices, weakness in heavyweight stocks and renewed concerns over US tariffs on generic drugs dented investor sentiment. The Nifty slipped below the key 24,000 mark, while the rupee weakened against the dollar and foreign institutional investors (FIIs) turned net sellers after a day's pause. In the corporate space, Dr Reddy's Laboratories reported a disappointing set of June-quarter earnings, adding to the cautious mood around pharmaceutical stocks.
Market at close: Dalal Street ends in red as Nifty closes around 23,900FIIs turn sellers again after a day's pause as markets end lower
Foreign institutional investors (FIIs) turned net sellers of Indian equities on Wednesday, offloading shares worth ₹819.20 crore on a provisional basis, according to exchange data.
Read more
Rupee falls to 96.34 against dollar after giving up gains as oil rally intensifies
The Indian rupee opened lower on Wednesday (July 22), reversing some of the gains from the previous session, as a rise in crude oil prices following fresh US-Iran strikes weighed on investor sentiment.
Read more
Also read: Brent crude prices cross $91, hit two-month high; Here are two main reasons why
Dr Reddy's Q1 Results: Semaglutide API provision weighs on profit; margin halves
Dr Reddy's Laboratories reported a weak set of earnings for the June quarter, with profit, revenue and operating performance missing CNBC-TV18 estimates by a wide margin. The pharmaceutical major also posted a sharp year-on-year decline across key financial metrics, underscoring pressure on profitability during the quarter.
Read more
Also Read:Eternal Q1 Results: Blinkit operating profit crosses ₹100 crore, Food delivery NOV up 20%
Can Dalal Street find its footing after Wednesday's rout?
After Wednesday's sharp sell-off, investors will look for signs of stability as elevated crude oil prices continue to dominate market sentiment. Besides the technical setup for the Nifty, traders will track key earnings, stock-specific developments and the pharmaceutical sector's response to US President Donald Trump's proposed tariffs on imported generic medicines.
Stocks to watch for July 23: HPCL, Dr Reddy's Lab, IndusInd Bank and more
From HPCL, Dr Reddy's Lab, IndusInd Bank and others reporting their Q1 results to Auto component maker Sona BLW Precision Forgings Ltd announcing a partnership with DENSO Corporation; these are stocks to track ahead of Thursday trading session.
Read more Nifty Outlook for July 23: Oil prices continue to play bummer as supports break
After having played where to go next for the first couple of days of the week, the Nifty 50 has taken a decisive leg down. Higher oil prices are to blame. Brent is back at $95 and Goldman Sachs is worried that if this disruption lasts longer, they could even go to $120 a barrel in the fourth quarter of the year.
Read more
Indian pharma weighs Trump tariff impact; industry body says US investments hinge on viability
India's pharmaceutical industry is assessing the implications of US President Donald Trump's proposed tariffs on imported generic medicines, but future investments in the US will continue to depend on commercial viability rather than policy announcements alone, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said.
Read more
From geopolitics to technology: Stories in focus
Donald Trump's approval of a Saudi nuclear cooperation deal added a fresh geopolitical dimension to developments in West Asia, while Sonam Wangchuk vowed to continue his hunger strike amid the ongoing NEET row. On the corporate front, Temasek reaffirmed its confidence in India's quick commerce opportunity, while Samsung's latest financial services push and OpenAI's AI testing disclosure kept the technology sector in focus.
Trump approves Saudi nuclear deal: Can Riyadh now build an atomic bomb?
US President Donald Trump has reportedly approved a nuclear cooperation agreement with Saudi Arabia that could eventually allow the kingdom to enrich uranium as part of its civilian nuclear programme.
Read more
Sonam Wangchuk to continue hunger strike until protesters get legal protection
Social activist Sonam Wangchuk has warned he will continue his hunger strike "indefinitely" unless the government guarantees that young protesters who marched on Parliament this week will face no legal action, in a letter to two Union Ministers that also credits them with a fresh assurance on compensation and accountability over an examination paper leak.
Read more
Also read: NEET row rocks Parliament again; govt ready for debate, Kharge demands education minister resign first
Samsung launches Galaxy Card in US: How the tech giant’s first credit card works
Samsung Electronics has entered the US credit card market with the launch of Samsung Galaxy Card, a co-branded credit card issued by Barclays US Consumer Bank and operating on the Visa network.
Read more
Also read: OpenAI's AI models hacked a rival startup without human help, company admits
Temasek unfazed by quick commerce wars, says ‘it’s just the tip of the iceberg’
Singapore state investor Temasek remains firmly bullish on India’s quick commerce opportunity despite intensifying competition from Amazon, Flipkart and Zepto, saying the sector is still in its infancy and has a long runway for growth.
Read more
/images/ppid_59c68470-image-178472516553028115.webp)
/images/ppid_59c68470-image-178456759156594873.webp)
/images/ppid_59c68470-image-178472506135618579.webp)
/images/ppid_59c68470-image-178472510292037505.webp)
/images/ppid_59c68470-image-17845975271092886.webp)
/images/ppid_59c68470-image-178470503058049085.webp)
/images/ppid_59c68470-image-178461505313635238.webp)
